Larimar Therapeutics, Inc. - LRMR

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 21
Latest filed: Mar 19, 2026
Form Count
8-K 9
4 8
SCHEDULE 13G/A 3
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Mar 19, 2026 8-K Mar 19, 2026 0001193125-26-115119 View
Mar 09, 2026 8-K Mar 09, 2026 0001193125-26-098493 View
Mar 02, 2026 SCHEDULE 13D/A 0001193805-26-000206 View
Mar 02, 2026 4 Feb 27, 2026 0001193125-26-085510 View
Mar 02, 2026 4 Feb 27, 2026 0001193125-26-085514 View
Mar 02, 2026 4 Feb 27, 2026 0001193125-26-085515 View
Mar 02, 2026 4 Feb 27, 2026 0001193805-26-000205 View
Feb 27, 2026 8-K Feb 25, 2026 0001193125-26-077646 View
Feb 24, 2026 8-K Feb 24, 2026 0001193125-26-065186 View
Feb 17, 2026 SCHEDULE 13G/A 0001346824-26-000047 View
Feb 12, 2026 SCHEDULE 13G/A 0001140361-26-005033 View
Jan 27, 2026 4 Jan 26, 2026 0001193125-26-024824 View
Jan 27, 2026 4 Jan 26, 2026 0001193125-26-024826 View
Jan 27, 2026 4 Jan 26, 2026 0001193125-26-024832 View
Jan 27, 2026 4 Jan 26, 2026 0001193125-26-024833 View
Jan 22, 2026 8-K Jan 21, 2026 0001193125-26-018664 View
Jan 12, 2026 8-K Jan 12, 2026 0001193125-26-010409 View
Dec 17, 2025 8-K Dec 16, 2025 0001193125-25-321738 View
Nov 10, 2025 8-K Nov 10, 2025 0001193125-25-273217 View
Nov 06, 2025 SCHEDULE 13G/A 0001104659-25-107757 View
Nov 05, 2025 8-K Nov 05, 2025 0001193125-25-265702 View